Cancer survivors are more than twice as likely to have problems with insomnia than the average adult. If left untreated, insomnia is associated with a broad range of medical and psychosocial consequences, including mortality. The cognitive-behavioral treatment of insomnia has been proven for decades to be the most effective treatment, but is rarely available in cancer populations because of poor screening practices and a limited supply of trained providers. Dr. Zhou will discuss his efforts to better understand insomnia in cancer populations, to adapt conventional treatment methods to improve treatment accessibility, and to consider intervention translation into public health settings.

About

The Center for Translational and Basic Research (CTBR) for Addressing Health Disparities and Improving Health Outcomes (formerly The Center for Study of Gene Structure and Function/Gene Center) is dedicated to enhancing infrastructure to support basic and translational/clinical research, and to reducing minority health disparities. The Center contains a cadre of 19 biomedical researchers focusing on the areas of Cancer, Neuro/Behavior, and Disease Prevention using telehealth e-platforms to serve the underserved populations.

Acknowledgements

The CTBR is supported by a Research Centers in Minority Institutions Program grant from the National Institute on Minority Health and Health Disparities (8 G12 MD007599) of the National Institutes of Health, the Weill Cornell Medical College Clinical & Translational Science Center (2UL1TR000457-06) of the National Center for Advancing Translational Sciences of the National Institutes of Health.